ClinicalTrials.gov
ClinicalTrials.gov Menu

Hematopoietic Stem Cell Therapy in Chronic Wounds Using a Pressure Sore Model

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00535548
Recruitment Status : Unknown
Verified September 2007 by University Hospital, Basel, Switzerland.
Recruitment status was:  Recruiting
First Posted : September 26, 2007
Last Update Posted : September 26, 2007
Sponsor:
Information provided by:
University Hospital, Basel, Switzerland

Brief Summary:

Aim of the study:

Evaluation of feasibility, safety and potential effects of stem cells on chronic wounds using a pressure sore model.

Clinical relevance:

  • Accelerated healing of uncomplicated wounds
  • Enhanced healing of complicated (chronic, non-healing) wounds

Study design:

  • Prospective controlled phase I/II study
  • Cohort of 5 patients in pilot study, then reevaluation

Patients:

- Para- and tetraplegic patients with sacral pressure sores grade III-IVA according to the classification of Daniel and Seiler

Methods:

1. First surgical intervention:

  • Radical debridement of pressure sore
  • Bone marrow harvest from the iliac crest
  • Isolation of hematopoietic stem cells, aiming to gain > 1 mio. CD 34+ cells per patient under GMP conditions

    3. Stem cell therapy (after 2 days)

  • Injection of stem cells in suspension (50'000 CD 34+ cells in 100 microliter saline per cm2 of wound surface) on one half of the total wound surface and cell-free saline on the other half as a control

    4. Second surgical intervention (after 3-4 weeks):

  • Complete excision of the wound
  • Closure of the defect by fasciocutaneous flap

    5. Evaluation of wound healing:

  • Clinical
  • 3D laser imaging
  • Histology
  • Growth factor assay

Condition or disease Intervention/treatment Phase
Chronic Wounds Pressure Sores Hematopoietic Stem Cells Wound Healing Biological: Stem cell therapy Phase 1

Study Type : Interventional  (Clinical Trial)
Intervention Model: Single Group Assignment
Masking: Single (Participant)
Primary Purpose: Basic Science
Official Title: Effect of Hematopoietic Stem Cells in Chronic Wounds Using a Pressure Sore Model: A Pilot Study on Feasibility, Safety and Potential Effects
Study Start Date : January 2007
Estimated Study Completion Date : December 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources


Intervention Details:
    Biological: Stem cell therapy
    Injection of a hematopoietic stem cell suspension (50'000 CD 34+ cells per microliter) into the wound (1 microliter per cm2 of wound surface)


Primary Outcome Measures :
  1. feasibility, safety, efficacy [ Time Frame: 1 yr ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Para- or tetraplegic
  • Sacral pressure sores
  • Grade III-IV according to classification of Daniel and Seiler

Exclusion Criteria:

  • Diabetes mellitus
  • Peripheral vascular disease
  • Coronary artery disease
  • Smoking
  • Steroids and other immunosuppressive drugs
  • Systemic autoimmune or rheumatoid diseases
  • HIV
  • Hepatitis B/C

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00535548


Contacts
Contact: Oliver Scheufler, MD, PhD +41-61-265 2525 oscheufler@gmx.net

Locations
Switzerland
Swiss Paraplegic Center Recruiting
Nottwil, Switzerland, 6207
Sub-Investigator: Zweifel-Schlatter Mirjam, MD         
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Investigators
Study Director: Oliver Scheufler, MD, PhD University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00535548     History of Changes
Other Study ID Numbers: 552
First Posted: September 26, 2007    Key Record Dates
Last Update Posted: September 26, 2007
Last Verified: September 2007

Keywords provided by University Hospital, Basel, Switzerland:
Chronic wounds
Pressure sores
Hematopoietic stem cells
Wound healing

Additional relevant MeSH terms:
Wounds and Injuries
Pressure Ulcer
Skin Ulcer
Skin Diseases